Analysis of the Stability of Stored Adenosine 5′-monophosphate used for Bronchoprovocation

Adenosine 5′-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just prior to each test in most of the studies. The objective of this study was to assess the stability of AMP solutions at different temperature...

Full description

Saved in:
Bibliographic Details
Published inPulmonary Pharmacology & Therapeutics Vol. 15; no. 2; pp. 157 - 160
Main Authors Martı́nez-Garcı́a, Miguel Angel, Perpiñá-Tordera, Miguel, Vila, Virtudes, Compte-Torrero, Luis, De Diego-Damiá, Alfredo, Macián-Gisbert, Vicente
Format Book Review Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.01.2002
Subjects
Online AccessGet full text
ISSN1094-5539
1522-9629
DOI10.1006/pupt.2001.0334

Cover

Loading…
Abstract Adenosine 5′-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just prior to each test in most of the studies. The objective of this study was to assess the stability of AMP solutions at different temperatures using a reversed-phase high-performance liquid chromatography assay. Sodium salt AMP solutions in concentrations of 0.03mg/ml and 400mg/ml were analyzed. One aliquot was kept at room temperature (20–25°C) and the others were refrigerated at 4°C. Room temperature stored samples were analyzed daily. Refrigerated stored samples were analyzed daily for first 15 days and then weekly. The duration of the study was 25 weeks. Samples were injected into the chromatograph column in quadruplicate and quantification was based on the arithmetic mean and standard deviation (±SD) of four measurements. Room temperature stored samples at concentrations of 0.03mg/ml showed a mean percent variation greater than 10% at day 9 and greater than 75% at day 14. Samples at concentrations of 400mg/ml maintained almost the initial concentration during the first 10 days, but decomposition occurred thereafter. In contrast, there was no significant degradation of refrigerated stored samples throughout the study period. We conclude the exposure to room temperature of AMP solutions results in a substantial loss of the initial concentration, but the shelf life of adequately prepared stock AMP solutions stored at 4°C is at least 25 weeks.
AbstractList Adenosine 5'-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just prior to each test in most of the studies. The objective of this study was to assess the stability of AMP solutions at different temperatures using a reversed-phase high-performance liquid chromatography assay. Sodium salt AMP solutions in concentrations of 0.03 mg/ml and 400 mg/ml were analyzed. One aliquot was kept at room temperature (20-25 degrees C) and the others were refrigerated at 4 degrees C. Room temperature stored samples were analyzed daily. Refrigerated stored samples were analyzed daily for first 15 days and then weekly. The duration of the study was 25 weeks. Samples were injected into the chromatograph column in quadruplicate and quantification was based on the arithmetic mean and standard deviation (+/-SD) of four measurements. Room temperature stored samples at concentrations of 0.03 mg/ml showed a mean percent variation greater than 10% at day 9 and greater than 75% at day 14. Samples at concentrations of 400 mg/ml maintained almost the initial concentration during the first 10 days, but decomposition occurred thereafter. In contrast, there was no significant degradation of refrigerated stored samples throughout the study period. We conclude the exposure to room temperature of AMP solutions results in a substantial loss of the initial concentration, but the shelf life of adequately prepared stock AMP solutions stored at 4 degrees C is at least 25 weeks.Adenosine 5'-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just prior to each test in most of the studies. The objective of this study was to assess the stability of AMP solutions at different temperatures using a reversed-phase high-performance liquid chromatography assay. Sodium salt AMP solutions in concentrations of 0.03 mg/ml and 400 mg/ml were analyzed. One aliquot was kept at room temperature (20-25 degrees C) and the others were refrigerated at 4 degrees C. Room temperature stored samples were analyzed daily. Refrigerated stored samples were analyzed daily for first 15 days and then weekly. The duration of the study was 25 weeks. Samples were injected into the chromatograph column in quadruplicate and quantification was based on the arithmetic mean and standard deviation (+/-SD) of four measurements. Room temperature stored samples at concentrations of 0.03 mg/ml showed a mean percent variation greater than 10% at day 9 and greater than 75% at day 14. Samples at concentrations of 400 mg/ml maintained almost the initial concentration during the first 10 days, but decomposition occurred thereafter. In contrast, there was no significant degradation of refrigerated stored samples throughout the study period. We conclude the exposure to room temperature of AMP solutions results in a substantial loss of the initial concentration, but the shelf life of adequately prepared stock AMP solutions stored at 4 degrees C is at least 25 weeks.
Adenosine 5′-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just prior to each test in most of the studies. The objective of this study was to assess the stability of AMP solutions at different temperatures using a reversed-phase high-performance liquid chromatography assay. Sodium salt AMP solutions in concentrations of 0.03mg/ml and 400mg/ml were analyzed. One aliquot was kept at room temperature (20–25°C) and the others were refrigerated at 4°C. Room temperature stored samples were analyzed daily. Refrigerated stored samples were analyzed daily for first 15 days and then weekly. The duration of the study was 25 weeks. Samples were injected into the chromatograph column in quadruplicate and quantification was based on the arithmetic mean and standard deviation (±SD) of four measurements. Room temperature stored samples at concentrations of 0.03mg/ml showed a mean percent variation greater than 10% at day 9 and greater than 75% at day 14. Samples at concentrations of 400mg/ml maintained almost the initial concentration during the first 10 days, but decomposition occurred thereafter. In contrast, there was no significant degradation of refrigerated stored samples throughout the study period. We conclude the exposure to room temperature of AMP solutions results in a substantial loss of the initial concentration, but the shelf life of adequately prepared stock AMP solutions stored at 4°C is at least 25 weeks.
Adenosine 5'-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just prior to each test in most of the studies. The objective of this study was to assess the stability of AMP solutions at different temperatures using a reversed-phase high-performance liquid chromatography assay. Sodium salt AMP solutions in concentrations of 0.03 mg/ml and 400 mg/ml were analyzed. One aliquot was kept at room temperature (20-25 degrees C) and the others were refrigerated at 4 degrees C. Room temperature stored samples were analyzed daily. Refrigerated stored samples were analyzed daily for first 15 days and then weekly. The duration of the study was 25 weeks. Samples were injected into the chromatograph column in quadruplicate and quantification was based on the arithmetic mean and standard deviation (+/-SD) of four measurements. Room temperature stored samples at concentrations of 0.03 mg/ml showed a mean percent variation greater than 10% at day 9 and greater than 75% at day 14. Samples at concentrations of 400 mg/ml maintained almost the initial concentration during the first 10 days, but decomposition occurred thereafter. In contrast, there was no significant degradation of refrigerated stored samples throughout the study period. We conclude the exposure to room temperature of AMP solutions results in a substantial loss of the initial concentration, but the shelf life of adequately prepared stock AMP solutions stored at 4 degrees C is at least 25 weeks.
Author Macián-Gisbert, Vicente
Martı́nez-Garcı́a, Miguel Angel
Perpiñá-Tordera, Miguel
Vila, Virtudes
De Diego-Damiá, Alfredo
Compte-Torrero, Luis
Author_xml – sequence: 1
  givenname: Miguel Angel
  surname: Martı́nez-Garcı́a
  fullname: Martı́nez-Garcı́a, Miguel Angel
  organization: From the Pneumology, Hospital Universitario La Fe, Valencia, Spain
– sequence: 2
  givenname: Miguel
  surname: Perpiñá-Tordera
  fullname: Perpiñá-Tordera, Miguel
  organization: From the Pneumology, Hospital Universitario La Fe, Valencia, Spain
– sequence: 3
  givenname: Virtudes
  surname: Vila
  fullname: Vila, Virtudes
  organization: Biochemical Services, Hospital Universitario La Fe, Valencia, Spain
– sequence: 4
  givenname: Luis
  surname: Compte-Torrero
  fullname: Compte-Torrero, Luis
  organization: From the Pneumology, Hospital Universitario La Fe, Valencia, Spain
– sequence: 5
  givenname: Alfredo
  surname: De Diego-Damiá
  fullname: De Diego-Damiá, Alfredo
  organization: From the Pneumology, Hospital Universitario La Fe, Valencia, Spain
– sequence: 6
  givenname: Vicente
  surname: Macián-Gisbert
  fullname: Macián-Gisbert, Vicente
  organization: From the Pneumology, Hospital Universitario La Fe, Valencia, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12090789$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtO3DAUQC0EKq9uWVZZdZfBj8Sxl1PUAhISC2CHZDnOtcZtxk5tB2l2_aZ-El9CwgALJFjZss651j2HaNcHDwidELwgGPPTYRzygmJMFpixagcdkJrSUnIqd6c7llVZ10zuo8OUfmOMm4rVX9A-oVjiRsgDdL_0ut8kl4pgi7yC4ibr1vUub-aHmxwidMWyAx-S81DUj__-l-vgw7AKaVjpDMWYJsKGWPyIwZtVGGJ4CEZnF_wx2rO6T_D15TxCd79-3p5dlFfX55dny6vSMNHkEqyABiQhVhpi2gpbWenGSMG5wNRAS22rJaZUd9wyWgvGG1HVLdWWNx2v2RH6vp07_f13hJTV2iUDfa89hDGphgjOBKET-O0FHNs1dGqIbq3jRr32mIBqC5gYUopglXH5eZcctesVwWrOrubsas6u5uyTtninvU3-SBBbAaYsDw6iSsaBN9C5CCarLriPVf5ONb3zzuj-D2w-E58ApJ6sVg
CitedBy_id crossref_primary_10_1016_j_anai_2014_10_012
crossref_primary_10_1016_j_ejpb_2020_10_017
crossref_primary_10_1016_j_arbres_2013_05_001
crossref_primary_10_1016_j_arbr_2013_07_001
crossref_primary_10_1016_j_ejpb_2014_04_008
Cites_doi 10.1111/j.1365-2222.1977.tb01448.x
10.1164/ajrccm.158.1.9703005
10.1136/thx.53.6.483
10.1016/0091-6749(93)90105-O
10.1164/ajrccm/147.3.553
10.1164/ajrccm/146.3.560
10.1136/thx.51.8.793
10.1164/ajrccm/144.2.352
10.1164/ajrccm/147.3.512
10.1136/thx.52.3.239
10.1183/09031936.00.15103000
10.1183/09031936.93.05060700
10.1046/j.1365-2222.2000.00819.x
10.1136/thx.50.5.511
10.1136/thx.51.8.799
10.1183/09031936.93.01100896
10.1378/chest.115.1.194
10.1136/thx.52.7.591
10.1016/0091-6749(91)90415-K
10.1164/ajrccm.155.3.9117020
10.1164/ajrccm/143.6.1329
ContentType Book Review
Journal Article
Copyright 2002 Elsevier Science Ltd
Copyright 2002 Elsevier Science Ltd.
Copyright_xml – notice: 2002 Elsevier Science Ltd
– notice: Copyright 2002 Elsevier Science Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1006/pupt.2001.0334
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1522-9629
EndPage 160
ExternalDocumentID 12090789
10_1006_pupt_2001_0334
S1094553901903347
Genre Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29P
4.4
457
4G.
53G
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ABZDS
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OI-
OU.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSP
SSZ
T5K
UHS
UNMZH
XPP
Z5R
ZMT
ZU3
~G-
AACTN
AAIAV
AATCM
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c387t-ef8e7e911f9c1cb40f94a7c9866802ceb2fba9022ad6f3258367845b2af67d653
IEDL.DBID .~1
ISSN 1094-5539
IngestDate Fri Sep 05 13:17:20 EDT 2025
Mon May 19 02:24:50 EDT 2025
Tue Jul 01 00:16:24 EDT 2025
Thu Apr 24 23:01:50 EDT 2025
Fri Feb 23 02:34:23 EST 2024
Tue Aug 26 16:51:48 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Adenosine 5′-monophosphate, Bronchoprovocation challenge, High-performance liquid chromatography
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright 2002 Elsevier Science Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c387t-ef8e7e911f9c1cb40f94a7c9866802ceb2fba9022ad6f3258367845b2af67d653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 12090789
PQID 71863812
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_71863812
pubmed_primary_12090789
crossref_citationtrail_10_1006_pupt_2001_0334
crossref_primary_10_1006_pupt_2001_0334
elsevier_sciencedirect_doi_10_1006_pupt_2001_0334
elsevier_clinicalkey_doi_10_1006_pupt_2001_0334
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2002-01-01
PublicationDateYYYYMMDD 2002-01-01
PublicationDate_xml – month: 01
  year: 2002
  text: 2002-01-01
  day: 01
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pulmonary Pharmacology & Therapeutics
PublicationTitleAlternate Pulm Pharmacol Ther
PublicationYear 2002
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Schoor, Joos, Kips, Drajesk, Carpertier, Pauwels (RF12) 1997; 155
Oosterhoff, Köeter, De Monchy, Postma (RF13) 1993; 147
Avital, Springer, Bar-Yishay, Godfrey (RF18) 1995; 50
Polosa, Ciamarra, Mangano, Prosperini, Pistorio, Vancheri (RF21) 2000; 15
Cockcroft, Killian, Mellon, Hargreaves (RF1) 1977; 7
Church, Holgate (RF8) 1993; 92
Marshik, Moghaddam, Tebbett, Hendeles (RF20) 1999; 115
O'Connor, Chung, Chen-Worsdell, Fuller, Barnes (RF6) 1991; 143
O'Connor, Ridge, Barnes, Fuller (RF11) 1992; 146
Wang, Wisniewski, Pavord, Knox, Tattersfield (RF15) 1996; 51
Polosa, Holgate (RF3) 1997; 52
Taylor, McGrath, Orr, Barnes, O'Connor (RF5) 1998; 53
Polosa, Rajakulasingam, Church, Holgate (RF7) 1992; 5
Richards, Simpson, Renwick, Holgate (RF10) 1988; 2
Polosa, Phillips, Rajakulasingam, Holgate (RF9) 1991; 87
Rutgers, Timens, Tzanakis, Kauffman, Van der Mark, Koëter (RF22) 2000; 30
Tan, McFarlane, Lipworth (RF24) 1997; 52
Aalbers, Kauffman, Köeter, Postma, De Vries, De Monchy (RF16) 1991; 144
Marcks, Yates, Sist, Ceyhan, De Campos, Scott, Barnes (RF14) 1996; 51
Pratter, Woodman, Irwin, Johnson (RF19) 1982; 126
Edbabge, Pavord, Wilding, Thompson-Coon, Tattersfield (RF2) 1997; 52
Oosterhoff, de Jong, Jansen, Koëter, Postma (RF4) 1993; 147
O'Connor (RF23) 1997; 52
De Gouw, Hendriks, Woltman, Twiss, Sterk (RF17) 1998; 158
Polosa (10.1006/pupt.2001.0334_RF3) 1997; 52
Marcks (10.1006/pupt.2001.0334_RF14) 1996; 51
Polosa (10.1006/pupt.2001.0334_RF9) 1991; 87
Edbabge (10.1006/pupt.2001.0334_RF2) 1997; 52
Taylor (10.1006/pupt.2001.0334_RF5) 1998; 53
O'Connor (10.1006/pupt.2001.0334_RF6) 1991; 143
Marshik (10.1006/pupt.2001.0334_RF20) 1999; 115
Rutgers (10.1006/pupt.2001.0334_RF22) 2000; 30
Oosterhoff (10.1006/pupt.2001.0334_RF4) 1993; 147
Polosa (10.1006/pupt.2001.0334_RF7) 1992; 5
O'Connor (10.1006/pupt.2001.0334_RF11) 1992; 146
O'Connor (10.1006/pupt.2001.0334_RF23) 1997; 52
Oosterhoff (10.1006/pupt.2001.0334_RF13) 1993; 147
Pratter (10.1006/pupt.2001.0334_RF19) 1982; 126
Polosa (10.1006/pupt.2001.0334_RF21) 2000; 15
Wang (10.1006/pupt.2001.0334_RF15) 1996; 51
Avital (10.1006/pupt.2001.0334_RF18) 1995; 50
Richards (10.1006/pupt.2001.0334_RF10) 1988; 2
Schoor (10.1006/pupt.2001.0334_RF12) 1997; 155
Aalbers (10.1006/pupt.2001.0334_RF16) 1991; 144
Cockcroft (10.1006/pupt.2001.0334_RF1) 1977; 7
Church (10.1006/pupt.2001.0334_RF8) 1993; 92
De Gouw (10.1006/pupt.2001.0334_RF17) 1998; 158
Tan (10.1006/pupt.2001.0334_RF24) 1997; 52
References_xml – volume: 5
  start-page: 700
  year: 1992
  end-page: 708
  ident: RF7
  article-title: Repeated inhalation of bradykinin attenuates adenosine 5′-monophosphate (AMP) induced bronchoconstriction in asthmatic airways
  publication-title: Eur Respir J
– volume: 126
  start-page: 717
  year: 1982
  end-page: 719
  ident: RF19
  article-title: Stability of stored methacholine chloride solutions. Clinically useful information
  publication-title: Am Rev Respir Dis
– volume: 147
  start-page: 553
  year: 1993
  end-page: 558
  ident: RF4
  article-title: Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking
  publication-title: Am Rev Respir Dis
– volume: 92
  start-page: 190
  year: 1993
  end-page: 194
  ident: RF8
  article-title: Adenosine induced bronchoconstriction and its inhibition by nedocromil sodium
  publication-title: J Allergy Clin Immunol
– volume: 51
  start-page: 799
  year: 1996
  end-page: 804
  ident: RF15
  article-title: Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5′-monophosphate challenge in asthma
  publication-title: Thorax
– volume: 30
  start-page: 657
  year: 2000
  end-page: 662
  ident: RF22
  article-title: Airway inflammation and hiperresponsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease
  publication-title: Clin Exp Allergy
– volume: 53
  start-page: 483
  year: 1998
  end-page: 489
  ident: RF5
  article-title: Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine 5′-monophosphate in asthma
  publication-title: Thorax
– volume: 51
  start-page: 793
  year: 1996
  end-page: 798
  ident: RF14
  article-title: Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate
  publication-title: Thorax
– volume: 158
  start-page: 315
  year: 1998
  end-page: 319
  ident: RF17
  article-title: Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma
  publication-title: Am J Respir Crit Care Med
– volume: 15
  start-page: 30
  year: 2000
  end-page: 35
  ident: RF21
  article-title: Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis
  publication-title: Eur Respir J
– volume: 52
  start-page: 919
  year: 1997
  end-page: 923
  ident: RF3
  publication-title: Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax
– volume: 87
  start-page: 939
  year: 1991
  end-page: 947
  ident: RF9
  article-title: The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma
  publication-title: J Allergy Clin Immunol
– volume: 147
  start-page: 512
  year: 1993
  end-page: 517
  ident: RF13
  article-title: Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects
  publication-title: Am Rev Respir Dis
– volume: 144
  start-page: 352
  year: 1991
  end-page: 357
  ident: RF16
  article-title: Dissimilarity in methacholine and adenosine 5′-monophosphate responsiveness 3 and 24
  publication-title: Am Rev Respir Dis
– volume: 52
  start-page: 608
  year: 1997
  end-page: 611
  ident: RF24
  publication-title: Loss of normal cyclical beta
– volume: 143
  start-page: 1329
  year: 1991
  end-page: 1333
  ident: RF6
  article-title: Effect of inhaled furosemide and bumetanide on adenosine 5′-monophosphate and sodium metasulfite-induced bronchoconstriction in asthmatic subjects
  publication-title: Am Rev Respir Dis
– volume: 2
  start-page: 896
  year: 1988
  end-page: 901
  ident: RF10
  article-title: Inhalation rate of sodium cromoglycate determines plasma pharmakinetics and protection against AMP-induced bronchoconstriction in asthma
  publication-title: Eur Respir J
– volume: 115
  start-page: 194
  year: 1999
  end-page: 199
  ident: RF20
  article-title: Degradation of histamine solutions used for broncoprovocation
  publication-title: Chest
– volume: 155
  start-page: 875
  year: 1997
  end-page: 880
  ident: RF12
  article-title: The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects
  publication-title: Am J Respir Crit Care Med
– volume: 52
  start-page: 239
  year: 1997
  end-page: 243
  ident: RF2
  article-title: Adenosine monophosphate and histamine induced bronchoconstriction; repetibility and proteccion by terbutaline
  publication-title: Thorax
– volume: 7
  start-page: 235
  year: 1977
  end-page: 243
  ident: RF1
  article-title: Bronchial reactivity to inhaled histamine: a method and clinical survey
  publication-title: Clin Allergy
– volume: 146
  start-page: 560
  year: 1992
  end-page: 564
  ident: RF11
  article-title: Greater effect of inhaled budesonide on adenosine 5′-monophosphate induced than on sodium-metabisulfite-induced bronchoconstriction in asthma
  publication-title: Am Rev Respir Dis
– volume: 50
  start-page: 511
  year: 1995
  end-page: 516
  ident: RF18
  article-title: Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease
  publication-title: Thorax
– volume: 52
  start-page: 591
  year: 1997
  end-page: 592
  ident: RF23
  article-title: Premenstrual asthma: still poorly understood
  publication-title: Thorax
– volume: 7
  start-page: 235
  year: 1977
  ident: 10.1006/pupt.2001.0334_RF1
  article-title: Bronchial reactivity to inhaled histamine: a method and clinical survey
  publication-title: Clin Allergy
  doi: 10.1111/j.1365-2222.1977.tb01448.x
– volume: 158
  start-page: 315
  year: 1998
  ident: 10.1006/pupt.2001.0334_RF17
  article-title: Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.158.1.9703005
– volume: 52
  start-page: 919
  year: 1997
  ident: 10.1006/pupt.2001.0334_RF3
  publication-title: Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax
– volume: 53
  start-page: 483
  year: 1998
  ident: 10.1006/pupt.2001.0334_RF5
  article-title: Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine 5′-monophosphate in asthma
  publication-title: Thorax
  doi: 10.1136/thx.53.6.483
– volume: 92
  start-page: 190
  year: 1993
  ident: 10.1006/pupt.2001.0334_RF8
  article-title: Adenosine induced bronchoconstriction and its inhibition by nedocromil sodium
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/0091-6749(93)90105-O
– volume: 147
  start-page: 553
  year: 1993
  ident: 10.1006/pupt.2001.0334_RF4
  article-title: Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/147.3.553
– volume: 146
  start-page: 560
  year: 1992
  ident: 10.1006/pupt.2001.0334_RF11
  article-title: Greater effect of inhaled budesonide on adenosine 5′-monophosphate induced than on sodium-metabisulfite-induced bronchoconstriction in asthma
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/146.3.560
– volume: 51
  start-page: 793
  year: 1996
  ident: 10.1006/pupt.2001.0334_RF14
  article-title: Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate
  publication-title: Thorax
  doi: 10.1136/thx.51.8.793
– volume: 144
  start-page: 352
  year: 1991
  ident: 10.1006/pupt.2001.0334_RF16
  article-title: Dissimilarity in methacholine and adenosine 5′-monophosphate responsiveness 3 and 24h after allergen challenge
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/144.2.352
– volume: 147
  start-page: 512
  year: 1993
  ident: 10.1006/pupt.2001.0334_RF13
  article-title: Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/147.3.512
– volume: 52
  start-page: 239
  year: 1997
  ident: 10.1006/pupt.2001.0334_RF2
  article-title: Adenosine monophosphate and histamine induced bronchoconstriction; repetibility and proteccion by terbutaline
  publication-title: Thorax
  doi: 10.1136/thx.52.3.239
– volume: 15
  start-page: 30
  year: 2000
  ident: 10.1006/pupt.2001.0334_RF21
  article-title: Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00.15103000
– volume: 5
  start-page: 700
  year: 1992
  ident: 10.1006/pupt.2001.0334_RF7
  article-title: Repeated inhalation of bradykinin attenuates adenosine 5′-monophosphate (AMP) induced bronchoconstriction in asthmatic airways
  publication-title: Eur Respir J
  doi: 10.1183/09031936.93.05060700
– volume: 30
  start-page: 657
  year: 2000
  ident: 10.1006/pupt.2001.0334_RF22
  article-title: Airway inflammation and hiperresponsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease
  publication-title: Clin Exp Allergy
  doi: 10.1046/j.1365-2222.2000.00819.x
– volume: 50
  start-page: 511
  year: 1995
  ident: 10.1006/pupt.2001.0334_RF18
  article-title: Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease
  publication-title: Thorax
  doi: 10.1136/thx.50.5.511
– volume: 51
  start-page: 799
  year: 1996
  ident: 10.1006/pupt.2001.0334_RF15
  article-title: Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5′-monophosphate challenge in asthma
  publication-title: Thorax
  doi: 10.1136/thx.51.8.799
– volume: 2
  start-page: 896
  year: 1988
  ident: 10.1006/pupt.2001.0334_RF10
  article-title: Inhalation rate of sodium cromoglycate determines plasma pharmakinetics and protection against AMP-induced bronchoconstriction in asthma
  publication-title: Eur Respir J
  doi: 10.1183/09031936.93.01100896
– volume: 115
  start-page: 194
  year: 1999
  ident: 10.1006/pupt.2001.0334_RF20
  article-title: Degradation of histamine solutions used for broncoprovocation
  publication-title: Chest
  doi: 10.1378/chest.115.1.194
– volume: 52
  start-page: 591
  year: 1997
  ident: 10.1006/pupt.2001.0334_RF23
  article-title: Premenstrual asthma: still poorly understood
  publication-title: Thorax
  doi: 10.1136/thx.52.7.591
– volume: 87
  start-page: 939
  year: 1991
  ident: 10.1006/pupt.2001.0334_RF9
  article-title: The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/0091-6749(91)90415-K
– volume: 155
  start-page: 875
  year: 1997
  ident: 10.1006/pupt.2001.0334_RF12
  article-title: The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.155.3.9117020
– volume: 52
  start-page: 608
  year: 1997
  ident: 10.1006/pupt.2001.0334_RF24
  publication-title: Loss of normal cyclical beta2 adrenoreceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients, Thorax
– volume: 126
  start-page: 717
  year: 1982
  ident: 10.1006/pupt.2001.0334_RF19
  article-title: Stability of stored methacholine chloride solutions. Clinically useful information
  publication-title: Am Rev Respir Dis
– volume: 143
  start-page: 1329
  year: 1991
  ident: 10.1006/pupt.2001.0334_RF6
  article-title: Effect of inhaled furosemide and bumetanide on adenosine 5′-monophosphate and sodium metasulfite-induced bronchoconstriction in asthmatic subjects
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/143.6.1329
SSID ssj0007435
Score 1.1925874
Snippet Adenosine 5′-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just...
Adenosine 5'-monophosphate (AMP) bronchial challenge has been shown to be very useful tool in the diagnosis of asthma. Freshly test solutions are prepared just...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 157
SubjectTerms Adenosine 5′-monophosphate, Bronchoprovocation challenge, High-performance liquid chromatography
Adenosine Monophosphate - analysis
Bronchial Provocation Tests
Chromatography, High Pressure Liquid
Drug Stability
Temperature
Title Analysis of the Stability of Stored Adenosine 5′-monophosphate used for Bronchoprovocation
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1094553901903347
https://dx.doi.org/10.1006/pupt.2001.0334
https://www.ncbi.nlm.nih.gov/pubmed/12090789
https://www.proquest.com/docview/71863812
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCqU9telr-0h1KOklii3rZR_D0rB9JCxNAjkUjC1LJBBs09097KX0N_Un9Zd0xo8sPWwPPRmExg9pPN-MpPkG4F1VKgQSn_C4Coor6QwnFOTSBGuldEUQlI18emZml-rTlb7agemYC0PHKgfb39v0zloPLdEwmlF7cxOdC4xMtKaYPYulVJRRrpQl_vyjH5tjHoiQutvxzBSn3iNxY2yidtV2pynFEclvA6ZtjmcHQCeP4CElJbB-Jf8x7Ph6D-6fDvvie3Aw7xmo14fsYpNQtThkB2y-4aZeP4FvIwkJawJD34-hs9kdj11TwzkG4L5ixxUxiOONmf798xdHRW3a62bRXqNfylYL7IGeLsMAvkbbSWsSTb_u9xQuTz5cTGd8KLDAnUztkvuQeuvR3IXMCVeqOGSqsC5LjUnjxGHQHcoiQ5QvKhNkolOJ0KZ0mRTB2Mpo-Qx266b2L4BR3Wr07WyshFM2pd1CV2pBXDdpiT7NBPg4urkb2MepCMZt3vMmm5xmg4piipxmYwLv7_q3Pe_G1p7ROFn5mE2K9i9HSNgqIe4k_tK1f8q8HfUgxx-QdlWK2jerRY7gjt8okgk879Vj875JnBGb_8v_eN4reNDVnekWe17D7vL7yr9B92dZ7nf6vQ_3jqdfv8zp-vHz7OwPPsoFjw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIvE4QXktr_qAyqVu4viVHFFFtUC3qtSt1ANSlDi2WgklEbt72AviN_GT-CXM5NEVh-XA1bKdxJ7MN-PxfAPwrioVAolPeFwFxZV0hhMKcmmCtVK6IgjKRp6dmeml-nylr3bgeMyFoWuVg-7vdXqnrYeWaFjNqL25iS4EeiZak8-exVIqewfuKi0tifbRj809D4RI3YU8M8Wp-8jcGJuoXbXddUpxRBNsQ6ZtlmeHQCeP4CFlJbD-KP8x7Ph6D-7NhsD4Hhyc9xTU60M232RULQ7ZATvfkFOvn8DXkYWENYGh8cfQ2uzux66p4QI9cF-xDxVRiOPETP_--YujpDbtdbNor9EwZasF9kBTl6EHX6PypEOJpj_4ewqXJx_nx1M-VFjgTqZ2yX1IvfWo70LmhCtVHDJVWJelxqRx4tDrDmWRIcwXlQky0alEbFO6TIpgbGW0fAa7dVP7F8CocDUadzZWwimbUrjQlVoQ2U1aolEzAT6ubu4G-nGqgvEt74mTTU67QVUxRU67MYH3t_3bnnhja89o3Kx8TCdFBZgjJmwdIW5H_CVs_xyzP8pBjn8ghVWK2jerRY7ojt8okgk878Vj875JnBGd_8v_eN4-3J_OZ6f56aezL6_gQVeEpjv5eQ27y-8r_wZtoWX5tpP1Pw4yBZA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+the+Stability+of+Stored+Adenosine+5%E2%80%B2-monophosphate+used+for+Bronchoprovocation&rft.jtitle=Pulmonary+Pharmacology+%26+Therapeutics&rft.au=Mart%C4%B1%CC%81nez-Garc%C4%B1%CC%81a%2C+Miguel+Angel&rft.au=Perpi%C3%B1%C3%A1-Tordera%2C+Miguel&rft.au=Vila%2C+Virtudes&rft.au=Compte-Torrero%2C+Luis&rft.date=2002-01-01&rft.pub=Elsevier+Ltd&rft.issn=1094-5539&rft.eissn=1522-9629&rft.volume=15&rft.issue=2&rft.spage=157&rft.epage=160&rft_id=info:doi/10.1006%2Fpupt.2001.0334&rft.externalDocID=S1094553901903347
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1094-5539&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1094-5539&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1094-5539&client=summon